Significantly, sarcopenia in heart failure patients with coronary artery disease (CAD) and unstable atherosclerotic plaques is marked by decreased IGF-1 expression in skeletal muscle, suggesting a potential role of IGF-1 as a positive modulator of muscle strength and function [8]. This evidence concerns the gene IGF1 and coronary artery disorder.